BioCentury
ARTICLE | Clinical News

EGEN-001: Phase I started

October 24, 2005 7:00 AM UTC

Expression Genetics started an open-label, dose-escalation Phase I trial in up to 18 patients. EGEN-001 has Orphan Drug designation in the U.S. for this indication. ...